CLDX
Price
$25.14
Change
-$0.24 (-0.95%)
Updated
Dec 20, 04:59 PM (EDT)
71 days until earnings call
ZLDPF
Price
$100.51
Change
+$0.71 (+0.71%)
Updated
Dec 20 closing price
Ad is loading...

CLDX vs ZLDPF

Header iconCLDX vs ZLDPF Comparison
Open Charts CLDX vs ZLDPFBanner chart's image
Celldex Therapeutics
Price$25.14
Change-$0.24 (-0.95%)
Volume$40.19K
CapitalizationN/A
Zealand Pharma A/S
Price$100.51
Change+$0.71 (+0.71%)
Volume$1.27K
CapitalizationN/A
CLDX vs ZLDPF Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. ZLDPF commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and ZLDPF is a StrongBuy.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (CLDX: $25.14 vs. ZLDPF: $100.51)
Brand notoriety: CLDX and ZLDPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 207% vs. ZLDPF: 116%
Market capitalization -- CLDX: $1.67B vs. ZLDPF: $7.52B
CLDX [@Biotechnology] is valued at $1.67B. ZLDPF’s [@Biotechnology] market capitalization is $7.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileZLDPF’s FA Score has 2 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • ZLDPF’s FA Score: 2 green, 3 red.
According to our system of comparison, ZLDPF is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 4 TA indicator(s) are bullish while ZLDPF’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 4 bullish, 4 bearish.
  • ZLDPF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than ZLDPF.

Price Growth

CLDX (@Biotechnology) experienced а -1.06% price change this week, while ZLDPF (@Biotechnology) price change was -10.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLDPF($7.52B) has a higher market cap than CLDX($1.67B). ZLDPF YTD gains are higher at: 80.611 vs. CLDX (-36.611). CLDX has higher annual earnings (EBITDA): -171.06M vs. ZLDPF (-1B). ZLDPF has more cash in the bank: 8.47B vs. CLDX (756M). CLDX has less debt than ZLDPF: CLDX (3.09M) vs ZLDPF (389M). ZLDPF has higher revenues than CLDX: ZLDPF (76.9M) vs CLDX (9.98M).
CLDXZLDPFCLDX / ZLDPF
Capitalization1.67B7.52B22%
EBITDA-171.06M-1B17%
Gain YTD-36.61180.611-45%
P/E RatioN/AN/A-
Revenue9.98M76.9M13%
Total Cash756M8.47B9%
Total Debt3.09M389M1%
FUNDAMENTALS RATINGS
CLDX vs ZLDPF: Fundamental Ratings
CLDX
ZLDPF
OUTLOOK RATING
1..100
1050
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
4721
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
8652
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (57) in the Biotechnology industry is in the same range as ZLDPF (80) in the null industry. This means that CLDX’s stock grew similarly to ZLDPF’s over the last 12 months.

ZLDPF's Profit vs Risk Rating (21) in the null industry is in the same range as CLDX (47) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to CLDX’s over the last 12 months.

ZLDPF's SMR Rating (94) in the null industry is in the same range as CLDX (96) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to CLDX’s over the last 12 months.

ZLDPF's Price Growth Rating (52) in the null industry is somewhat better than the same rating for CLDX (86) in the Biotechnology industry. This means that ZLDPF’s stock grew somewhat faster than CLDX’s over the last 12 months.

ZLDPF's P/E Growth Rating (5) in the null industry is significantly better than the same rating for CLDX (100) in the Biotechnology industry. This means that ZLDPF’s stock grew significantly faster than CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXZLDPF
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
56%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
52%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
45%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
57%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 6 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 4 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
59%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 6 days ago
63%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMGRX143.871.65
+1.16%
Janus Henderson Enterprise I
GEIYX16.620.17
+1.03%
GuideStone Funds Growth Equity Idx Instl
IIRLX42.450.42
+1.00%
Voya Russell Large Cap Index Port I
VFPIX18.500.09
+0.49%
Private Capital Management Value I
DFVIX17.430.05
+0.29%
DFA International Value III

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with KRYS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-0.95%
KRYS - CLDX
55%
Loosely correlated
+2.49%
BEAM - CLDX
43%
Loosely correlated
+8.04%
AXON - CLDX
43%
Loosely correlated
+2.60%
NTLA - CLDX
41%
Loosely correlated
+0.83%
EDIT - CLDX
39%
Loosely correlated
-2.24%
More

ZLDPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
+0.71%
KRYS - ZLDPF
46%
Loosely correlated
+2.49%
CLDX - ZLDPF
30%
Poorly correlated
-0.95%
NERV - ZLDPF
22%
Poorly correlated
+0.93%
SNDX - ZLDPF
22%
Poorly correlated
+1.79%
MIST - ZLDPF
22%
Poorly correlated
+4.96%
More